Researchers found that Perlecan deficiency causes axonal segments to break apart during development, leading to synaptic connection loss. The protein's critical role depends on its secretion from multiple cell types, not just neurons.
A team of researchers from China and the UK has developed new ways to optimise the production of solar fuels by creating novel photocatalysts. These photocatalysts, such as titanium dioxide with boron nitride, can absorb more wavelengths of light and produce more hydrogen compared to traditional methods.
A new study found that a vaccine against the deadly chytrid fungus in frogs can shift the composition of the microbiome, making frogs more resilient to future exposure. The researchers applied a non-lethal dosage of a metabolic product created by the chytrid fungus to tadpoles and observed a protective shift in the microbiome.
SourcePenn State·JournalPhilosophical Transactions of the Royal Society B Biological Sciences·TypeExperimental study·DateJun 11, 2023
Researchers investigated the tradeoff between reducing CO2 emissions and increasing renewable energy supply in office buildings. They found that access to the power grid can mitigate the impact of weather variability, but extreme weather events increase battery storage costs.
Researchers at NYU Abu Dhabi identified microRNAs associated with a weakened immune response and ICU admission. The study provides new insights into how patient genetic makeup affects disease severity and offers potential biomarkers for disease monitoring.
Researchers have developed a polygenic risk score for colorectal cancer, which can estimate an individual's likely disease risk and identify those who may benefit from earlier screening. The score can also help determine more appropriate ages to start screening based on genetic risk.
Researchers have developed an early detection algorithm to predict patients with Xeroderma pigmentosum who may develop neurodegeneration. The study used pluripotent stem cells and multi-omic technologies to identify possible drug targets, potentially slowing or halting the onset of neurodegeneration.